Migraine is a severe headache accompanied by nausea, vomiting, light and sound sensitivity. It is caused by vasodilation of cranial blood vessels. Treatment includes acute medications like triptans and ergot alkaloids to constrict vessels and relieve symptoms. Prophylactic drugs like beta-blockers, antidepressants, and anticonvulsants are used to reduce migraine frequency. Triptans are the most effective acute treatment but can have cardiovascular side effects, while ergot alkaloids are less tolerated but more specific vasoconstrictors. Prophylaxis is recommended for those with frequent or severe migraines.
learning objective includes : pathogenesis,clinical features, classification of migraine, pharmacology about specific antimigraine drugs, coverage to newer triptan- Lasmiditan and newer prophylactic drug Erenumab a CGRP receptor antagonist.
Autacoids - pharmacological actions and drugs related to them. SIVASWAROOP YARASI
Autacoids or "autocoids" are biological factors which act like local hormones, have a brief duration, and act near the site of synthesis. The word autacoids comes from the Greek "autos" (self) and "acos" (relief, i.e. drug).
learning objective includes : pathogenesis,clinical features, classification of migraine, pharmacology about specific antimigraine drugs, coverage to newer triptan- Lasmiditan and newer prophylactic drug Erenumab a CGRP receptor antagonist.
Autacoids - pharmacological actions and drugs related to them. SIVASWAROOP YARASI
Autacoids or "autocoids" are biological factors which act like local hormones, have a brief duration, and act near the site of synthesis. The word autacoids comes from the Greek "autos" (self) and "acos" (relief, i.e. drug).
Histamine is a biogenic amine present in many animal and plant tissues that function as neurotransmitters and are also found in non-neural tissues, have complex physiologic and pathologic effects through multiple receptor subtypes, and are often released locally.
It is also present in venoms and stinging secretions. It is synthesized by decarboxylation of the amino acid, histidine. Histamine is mainly present in storage granules of mast cells in tissues like skin, lungs, liver, gastric mucosa, placenta, etc. It is one of the mediators involved in inflammatory and hypersensitivity reactions.
5-Hydroxytryptamine & it’s Antagonist is a Topic in Pharmacology which will defiantly Help You in pharmacy field All information is related to pharmacology drug acting and it's effect on body. it is collage project given by our department i would like to share with you.
Histamine is a biogenic amine present in many animal and plant tissues that function as neurotransmitters and are also found in non-neural tissues, have complex physiologic and pathologic effects through multiple receptor subtypes, and are often released locally.
It is also present in venoms and stinging secretions. It is synthesized by decarboxylation of the amino acid, histidine. Histamine is mainly present in storage granules of mast cells in tissues like skin, lungs, liver, gastric mucosa, placenta, etc. It is one of the mediators involved in inflammatory and hypersensitivity reactions.
5-Hydroxytryptamine & it’s Antagonist is a Topic in Pharmacology which will defiantly Help You in pharmacy field All information is related to pharmacology drug acting and it's effect on body. it is collage project given by our department i would like to share with you.
Migraines are severe, debilitating headaches that are usually characterized by an intense throbbing or pulsing in one area of your head. They can include sensitivity to light, sound, and smell, create visual disturbances such as auras, and can even cause nausea or vomiting. They are more than a headache and can affect your everyday life.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
2. Learning Outcomes….
• Define migraine.
• Explain the biological basis of migraine & describe the types of
migraine.
• List the drugs used in the treatment of migraine.
• Explain the pharmacodynamics of different drugs used in the
treatment of migraine.
• Explain the pharmacokinetics of various drugs used in the treatment
of migraine.
3. Definition
• Migraine is a severe, unilateral, pulsating headache that typically lasts
from 2- 72 hrs
Headache is accompanied by nausea, vomiting, photophobia and
phonophobia
Headache is worsened by physical activity
Women are threefold more likely than men to experience migraine
4. Types of migraine
Classical migraine
• Migraine with preceding neurological
symptoms called “aura”
• Aura can be visual, sensory, and/or
cause speech or motor disturbances
• Visual auras (flashes, zigzag lines,
glare) occur 20-40 mins before
headache begins
Common migraine
• There is no preceding aura
• Majority of patients with migraine do
not have an aura
5. Severity of migraine
Mild
• Less than one
attack per
month
• Tolerable
headache
• Upto 8 hrs
Moderate
• More than one
attack per month
• More intense
throbbing headache
• Patient is
functionally
impaired
• Accompanied by
nausea and
vomiting
Severe
• 2-3 attacks per
month
• Severe throbbing
headache
accompanied with
vomiting
• Patient is severely
incapacitated
• Lasts for 12-48hrs
6. Biological basis of migraine
Depression of neuronal activity and reduced blood flow in the posterior
cerebral hemispheres causes “aura”
Hypoperfusion spreads forward over the surface of cortex
Followed by intracranial and extracranial arterial vasodilation
Release of inflammatory molecules (Substance P, neurokinin and CGRP)
Vasodilation stretches the duramater….which causes throbbing pain
7. Treatment of migraine
Drug therapy:
Symptomatic treatment of
acute migraine
1. Non-specific drugs
2. Specific antimigraine drugs
Prophylactic therapy
Non pharmacological
measures:
• Avoid triggers
• Meditation
• Yoga
• Relaxation therapy
• Psychotherapy
8. Drug therapy of acute migraine
Non specific drugs
• Analgesics
• NSAIDs
• Antiemetics
Specific antimigraine drugs
• Triptans
• Ergot alkaloids
9. Nonspecific drugs for acute migraine
• Paracetamol
• Aspirin
Analgesics
• Ibuprofen/Diclofenac
/Ketorolac/Naproxen
• They can be used in
combination with
caffeine/codeine/dia
zepam
NSAIDs
• Metoclopramide
• Domeperidone
• Diphenhydramine
• Promethazine
Antiemetics
10. Triptans
• Sumatriptan
• Naratriptan
• Rizatriptan
• Eletriptan
• Almotriptan
• Frovatriptan
• Zolmitriptan
• Sumatriptan
Given by oral/subcutaneous/
intranasal route
• Zolmitriptan
Given by oral route/ Nasal spray
All other triptans are given orally
Sumatriptan was the first available
triptan and is a prototype of the
class
11. Triptans
• Administered in the prodromal phase – it can rapidly terminate an
attack
• Better tolerated than ergot alkaloids
• Suppresses nausea (unlike ergot alkaloids)
• 70% patients respond to triptans
…relief from headache in 1-2 hrs when drug is taken orally
…when given parenterally, action begins in 20 mins
…Headaches recurs within 24 - 48 hrs after single dose
12. Mechanism of action of Triptans
• 5HT 1D/1B receptor agonists
The triptans have at least 3 distinct modes of action:
Vasoconstriction of painfully distended intracranial extra-cerebral
vessels
Inhibition of release of vasoactive neuropeptides by trigeminal
terminals innervating the intracranial vessels and dura mater.
Inhibition of nociceptive neurotransmission within the
trigeminocervical complex in the brainstem and upper spinal cord.
13. Triptans
Side effects:
Significant elevation of blood pressure and cardiac events have been
reported with triptan use
Contraindicated in patients with risk factors for CAD
Should not be used with ergot alkaloids
Should not be used with MAO inhibitors
Other side effects:
• Pain and pressure sensation in chest, neck, throat, and jaw
• Dizziness and malaise
14. Ergot alkaloids
• Obtained from the fungus Ergot (Claviceps purpurea)
…..grows on rye, millet, other grains. The grain is replaced by hard
“Sclerotium”
• Ergot alkaloids used in migraine are:
Ergotamine
Dihydroergotamine
15. Ergot alkaloids
Given in prodromal phase – it can abort an attack
Ergotamine – given by oral/sublingual route
Partial agonist of 5-HT 1B/1D located on intracranial blood vessels
Also binds to α receptors and dopamine receptors
Constricts dilated cranial vessels (5- HT1 action)
Reduces neurogenic inflammation
1mg given orally every half hour till relief or upto maximum 6 mg
16. Ergotamine
• Vasoconstrictor
Therefore cannot be administered to patients with
coronary diseases
• In addition, ergotamine..
Inhibits release of calcitonin gene-related peptide
(CGRP) and other inflammatory mediators
Interact with many different neurotransmitter
receptors (α and dopamine) thus, not specific
17. Ergotamine
Novel drugs: CGRP-receptor antagonists
are being explored for treatment of
migraine
Ergotamine also inhibits
the release of
inflammatory mediators
like CGRP
18. Ergotamine
• Ergotamine has erratic oral absorption…..gastric stasis during
migraine reduces absorption
• Metoclopramide improves the absorption of ergotamine by reducing
gastric stasis
• The elimination of ergotamine is biphasic; half-lives of about 2 and 21
hours have been reported for the 2 phases, respectively
20. Ergotamine & Dihydroergotamine
• Side effects
Nausea and vomiting (give
antiemetics)
Can cause dull background headache
Dependence and rebound headaches
occur
• Contraindicated in :
Pregnancy……….can cause fetal
distress and miscarriages
Peripheral vascular disease and
CAD…...because they are significant
vasoconstrictors
…..Used only when triptans fail
22. Prophylaxis of migraine
They are used if:
• Attack occurs two or more times a month
• Headaches are severe
• Headaches are complicated by serious neurological signs
Several classes of drugs are effective in reducing the frequency and
severity of migraine attacks.
Prophylactic therapy does not abort an attack !!!
23. Prophylaxis of migraine
• Drugs which can be used for prophylaxis of migraine:
β-blockers are the drug of choice….(Propranolol 40-160 mg BD)
Tricyclic antidepressants: Amitryptyline
Calcium channel blockers: Flunarizine, Verapamil
Anticonvulsants:
Valproic acid/Gabapentin/Topiramate
Editor's Notes
Calcitonin gene related peptide..(CGRP) is a potent vasodilator